Skip to content

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00179218
Enrollment
19
Registered
2005-09-15
Start date
2005-04-30
Completion date
2007-01-31
Last updated
2009-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Brief summary

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

Interventions

oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months

BEHAVIORALexercise

leg press exercise; every other day, 3 days per week, for 6 months

Sponsors

Vanderbilt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program; * Adequately dialyzed (Kt/V ≥ 1.2). * Age ≥ 18 years old.

Exclusion criteria

* Patients unable to perform exercise due to cardiovascular disease, osteoarthritis, etc., as determined by the PI and the primary physician of the subject. * Pregnant women. * Patients hospitalized within the last month prior to the study.

Design outcomes

Primary

MeasureTime frame
increase in lean body mass12 months

Secondary

MeasureTime frame
increase in physical functioning12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026